Medications and Sexual Function · Clinical Exercise

What the Drug Is Doing

Four mechanisms account for most medication-related sexual difficulty you will meet in practice. This exercise is about recognising which one is operating, and about where your scope ends.

What this exercise practises

Sorting medications and presenting patterns by mechanism, resisting both dismissal and confident attribution when the evidence is heterogeneous, and separating what a counsellor does from what only a prescriber does.

Calibrated for counselling practice. No doses, no interactions, no prescribing decisions. The test is whether you could describe what you are seeing to a prescriber and explain the mechanism to a client without overstating it.

Estimated time to complete this exercise: 25 minutes

1Mechanisms
2Patterns
3The pill
4Scope
5After stopping
6Close

Before you begin

How this one works

Four mechanisms account for most medication-related sexual difficulty you will encounter. The first two parts are about recognising which one is operating from the pattern a client describes.
Nothing here asks you to know doses, interactions or prescribing decisions. The calibration test is whether you could describe what you are seeing to a prescriber and explain the mechanism to the client.
Two parts are specifically about what you must not do. Advising a client on whether to stop or change a medication is outside scope, and it appears in this exercise as a wrong answer rather than as a footnote.
Everything is multiple choice or sorting, with feedback on every answer. Nothing is graded and nothing is recorded.

Medication-related sexual difficulty is among the most common contributors you will meet and among the least assessed, for two reasons: prescribers often do not ask at baseline, and clients often do not report it unless asked.

References

  1. Healy, D., Le Noury, J., & Mangin, D. (2018). Enduring sexual dysfunction after treatment with antidepressants, 5α-reductase inhibitors and isotretinoin: 300 cases. International Journal of Risk & Safety in Medicine, 29(3–4), 125–134. https://doi.org/10.3233/JRS-180744
  2. Montejo, A. L., Llorca, G., Izquierdo, J. A., & Rico-Villademoros, F. (2001). Incidence of sexual dysfunction associated with antidepressant agents: A prospective multicenter study of 1022 outpatients. Journal of Clinical Psychiatry, 62(Suppl. 3), 10–21.
  3. Sanders, S. A., Graham, C. A., Bass, J. L., & Bancroft, J. (2001). A prospective study of the effects of oral contraceptives on sexuality and well-being and their relationship to discontinuation. Contraception, 64(1), 51–58. https://doi.org/10.1016/S0010-7824(01)00218-9
  4. Serretti, A., & Chiesa, A. (2009). Treatment-emergent sexual dysfunction related to antidepressants: A meta-analysis. Journal of Clinical Psychopharmacology, 29(3), 259–266. https://doi.org/10.1097/JCP.0b013e3181a5233f